Highlights InVivo Therapeutics Holdings Corp.

Equities

NVIV

US46186M6057

Market Closed - OTC Markets Other stock markets 03:52:07 2024-05-28 pm EDT			5-day change	1st Jan Change
0.3984 ^USD	+2.15%		+3.40%	-45.42%

Apr. 16	North American Morning Briefing : Powell Comments, -2-	DJ
Apr. 02	North American Morning Briefing : Stocks Seen -2-	DJ

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

North American Morning Briefing : Stocks Seen -2-	Apr. 02	DJ
InVivo Therapeutics Holdings Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 08	CI
InVivo Therapeutics Holdings Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-09	CI
Australia's United Malt agrees to $1 bln takeover offer from France's InVivo	23-07-02	RE
Trio of French businessmen plan counter-offer for Casino	23-06-08	RE
Trio of French businessmen plan counter-offer for Casino	23-06-08	RE
InVivo Therapeutics Holdings Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI
France's InVivo offers close to $1 bln for Australia's United Malt	23-03-27	RE
France's InVivo placed bid for Australia's United Malt -report	23-03-27	RE
InVivo Therapeutics Holdings Corp. Announces Topline Data from Pivotal INSPIRE 2.0 Study in Acute Spinal Cord Injury	23-03-09	CI
InVivo Therapeutics Holdings Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-01	CI
France's InVivo to buy one of the world's oldest malthouses in Belgium	23-01-02	RE
InVivo Therapeutics Holdings Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-07	CI
InVivo Therapeutics Holdings Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-08	CI
InVivo Therapeutics Completes Enrollment in Acute Spinal Cord Injury Study	22-06-02	MT
InVivo Therapeutics Holdings Corp. Announces Completion of Enrollment for the INSPIRE 2.0 Acute Spinal Cord Injury Study	22-06-02	CI
InVivo Therapeutics Holdings Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-10	CI
Reverse Split: 1 of 25	22-04-26	FA
InVivo Therapeutics Holdings Corp. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-07	CI
InVivo Therapeutics Holdings Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-10	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights InVivo Therapeutics Holdings Corp.

Equities

NVIV

US46186M6057

Highlights

Filters